Rosemary Versteegen, PhDCEO at ISIA
After receiving her Degrees from the University of Glasgow in Scotland, Dr Versteegen studied at Cambridge University, England, and the National Institutes of Health, Washington D.C. Subsequent to several years as a staff scientist, she joined the biotech start up BRL in 1982. She was with Life Technologies in all it’s incarnations until the Invitrogen acquisition in 2000, holding positions such as Vice president of New Business Development, Manufacturing and Regulatory Affairs. After several years as a consultant, she was instrumental in founding the International Serum Industry Association (ISIA) in 2006. She has held the position of CEO since the inception of the Association.